Alector, Inc. Variable Lease, Cost
Alector, Inc. (ALEC) reported Variable Lease, Cost of $3.67 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2026-02-25
- Alector, Inc. variable lease, cost for the quarter ending 2019-12-31 was $425.00K.
- Alector, Inc. variable lease, cost for the quarter ending 2019-09-30 was $425.00K.
- Alector, Inc. variable lease, cost for the quarter ending 2019-06-30 was $294.00K.
- Alector, Inc. variable lease, cost for the quarter ending 2019-03-31 was $184.00K.
- Alector, Inc. variable lease, cost for fiscal 2025 was $3.67M, a 7.74% increase from fiscal 2024.
- Alector, Inc. variable lease, cost for fiscal 2024 was $3.41M, a 8.29% increase from fiscal 2023.
- Alector, Inc. variable lease, cost for fiscal 2023 was $3.15M, a 13.07% increase from fiscal 2022.
- Alector, Inc. variable lease, cost for fiscal 2022 was $2.79M, a 8.57% decline from fiscal 2021.
| Period end | Variable Lease, Cost 3 month | Variable Lease, Cost 6 month | Variable Lease, Cost 9 month | Variable Lease, Cost 12 month |
|---|---|---|---|---|
| 2025-12-31 | $3.67M 10-K · filed 2026-02-25 | |||
| 2024-12-31 | $3.41M 10-K · filed 2026-02-25 | |||
| 2023-12-31 | $3.15M 10-K · filed 2025-02-26 | |||
| 2022-12-31 | $2.79M 10-K · filed 2025-02-26 | |||
| 2021-12-31 | $3.05M 10-K · filed 2024-02-27 | |||
| 2020-12-31 | $2.25M 10-K · filed 2023-02-28 | |||
| 2019-12-31 | $425.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $850.00K derived: sum of 2 quarters · filed 2022-02-24 | $1.14M derived: sum of 3 quarters · filed 2022-02-24 | $1.33M 10-K · filed 2022-02-24 |
| 2019-09-30 | $425.00K 10-Q · filed 2019-11-12 | $719.00K derived: sum of 2 quarters · filed 2019-11-12 | $903.00K 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $294.00K 10-Q · filed 2019-08-12 | $478.00K 10-Q · filed 2019-08-12 | ||
| 2019-03-31 | $184.00K 10-Q · filed 2019-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |